Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-18

Clinical Trial Update: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial assessing immunogenicity and safety of the Japanese Encephalitis Vaccine when administered with the MMR vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: PATH | Conditions: Encephalitis, Japanese, Measles | Phase 4 | Status: COMPLETED | Results posted: 2020-09-18